NEOG * Stock Overview
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Neogen Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$377.71 |
| 52 Week High | US$377.71 |
| 52 Week Low | US$302.00 |
| Beta | 1.05 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 25.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| NEOG * | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how NEOG * performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how NEOG * performed against the MX Market.
Price Volatility
| NEOG * volatility | |
|---|---|
| NEOG * Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: NEOG * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NEOG *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 2,640 | John Adent | www.neogen.com |
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
Neogen Corporation Fundamentals Summary
| NEOG * fundamental statistics | |
|---|---|
| Market cap | Mex$62.29b |
| Earnings (TTM) | -Mex$476.51m |
| Revenue (TTM) | Mex$16.48b |
3.8x
P/S Ratio-130.7x
P/E RatioIs NEOG * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEOG * income statement (TTM) | |
|---|---|
| Revenue | US$919.09m |
| Cost of Revenue | US$455.39m |
| Gross Profit | US$463.69m |
| Other Expenses | US$490.27m |
| Earnings | -US$26.58m |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 50.45% |
| Net Profit Margin | -2.89% |
| Debt/Equity Ratio | 28.2% |
How did NEOG * perform over the long term?
See historical performance and comparison